Stockscreener 앱 받기
6.43
9.05%
-0.64
시장 영업 전:
5.50
-0.93
-14.46%
전일 마감가:
$7.07
열려 있는:
$6.9
하루 거래량:
50,650
Relative Volume:
4.30
시가총액:
$32.58M
수익:
$2.05B
순이익/손실:
$-45.99M
주가수익비율:
-11.41
EPS:
-0.5634
순현금흐름:
$5.54M
1주 성능:
-7.81%
1개월 성능:
-8.01%
6개월 성능:
-27.34%
1년 성능:
-17.56%
1일 변동 폭
$6.10
$6.90
1주일 범위
$6.10
$7.08
52주 변동 폭
$4.145
$11.90
111 Inc Adr Stock (YI) Company Profile
YI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
YI
111 Inc Adr
|
6.43 | 61.28M | 2.05B | -45.99M | 5.54M | -0.5634 |
|
MCK
Mckesson Corporation
|
686.64 | 84.71B | 377.60B | 3.35B | 5.67B | 25.08 |
|
COR
Cencora Inc
|
291.61 | 56.20B | 316.65B | 1.91B | 1.14B | 9.72 |
|
CAH
Cardinal Health Inc
|
148.78 | 35.70B | 222.58B | 1.57B | 1.85B | 6.45 |
|
HSIC
Henry Schein Inc
|
69.58 | 8.37B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.71 | 955.61M | 2.22M | -5.63M | -1.68M | -0.24 |
111 Inc Adr Stock (YI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-04-15 | 재개 | Citigroup | Buy |
111 Inc Adr 주식(YI)의 최신 뉴스
Exit strategy if you’re trapped in Nova Ltd.2025 Technical Patterns & Fast Entry High Yield Tips - Newser
111 Inc. Depositary Receipt recovery potential after sell offQuarterly Profit Review & Real-Time Stock Entry Alerts - Newser
111’s (YI) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World
111 Inc. Depositary Receipt stock retracement – recovery analysis2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
How to recover losses in 111 Inc. Depositary Receipt stockJuly 2025 PostEarnings & Technical Pattern Alert System - Newser
What data driven models say about 111 Inc. Depositary Receipt’s futureMarket Growth Review & Free AI Powered Buy and Sell Recommendations - Newser
Does 111 Inc. Depositary Receipt show high probability of reboundWeekly Stock Recap & High Accuracy Buy Signal Tips - Newser
Intraday pattern recognizer results for Biomea Fusion Inc.Long Setup & Fast Entry and Exit Trade Plans - Newser
Qlaris Bio Announces First Patient Dosed in Phase II Nightingale Clinical Trial in Normal Tension Glaucoma Patients - PharmiWeb.com
Can New Pacific Metals Corp. recover in the next quarterEntry Point & Low Drawdown Trading Strategies - Newser
Heatmap analysis for 111 Inc. Depositary Receipt and competitorsJuly 2025 Breakouts & Verified Chart Pattern Signals - Newser
What does recent volatility data suggest for 111 Inc. Depositary ReceiptTrade Volume Summary & Entry Point Confirmation Signals - Newser
$111M Share Buyback: GigaCloud Tech Marks 163% Stock Growth Since IPO with New Repurchase Plan - Stock Titan
Is 111 Inc. Depositary Receipt a Top Dividend Stock to Watch in 20252025 Top Gainers & Fast Gain Stock Tips - Newser
Using portfolio simulators with 111 Inc. Depositary Receipt includedDividend Hike & Momentum Based Trading Ideas - Newser
Leading vs lagging indicators on VinFast Auto Ltd. Equity Warrant performanceProfit Target & Safe Capital Growth Plans - Newser
111 Inc. Depositary Receipt Stock Performance After Earnings: Historical InsightsDividend Hike & Growth Oriented Trading Recommendations - Newser
111 (NASDAQ:YI) Earns “Sell (D-)” Rating from Weiss Ratings - Defense World
Comparing Schrodinger (NASDAQ:SDGR) and 111 (NASDAQ:YI) - Defense World
scPharmaceuticals Strengthens IP Portfolio with 5 New Patents for Innovative Heart Failure Treatment - Stock Titan
Tron Achieves Remarkable Turnaround: $1.47M Profit and 3,500% Equity Surge in Q2 2025 - Stock Titan
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease - Novartis
FS KKR Capital Corp. stock outlook for YEAROversold Stock Bounce Playbook Generator - Newser
Orchestra BioMed Secures Over $111 Million in Proceeds and - GlobeNewswire
Can volume confirm reversal in 111 Inc. Depositary ReceiptAlpha Trade Flow With Risk Calibration - Newser
Trend analysis for PROV this weekFree Entry Alert Based on Volume Spikes - Newser
Brokerages Set Enova International, Inc. (NYSE:ENVA) Target Price at $111.00 - Defense World
Is 111 Inc. Depositary Receipt a growth stock or a value stockBest Dividend Report With High Returns - Jammu Links News
111 (NASDAQ:YI) Given Sell (E+) Rating at Weiss Ratings - Defense World
President Marcos, VP greet INC on its 111th anniversary - Philstar.com
Palace congratulates INC on 111th anniversary - GMA Network
Macro Trends and Their Impact on Giriraj Civil Developers Limited (GIRIRAJ)Phenomenal wealth increase - Autocar Professional
India Champions vs South Africa Champions, WCL 2025 Highlights: IND 111/9 (18.2), SA 208/6 (20) | SAC Beat INC By 88 Runs Via DLS - myKhel
111 Inc. Depositary Receipt Stock Analysis and ForecastFree Market Dynamics Reports - jammulinksnews.com
Is 111 Inc. Depositary Receipt a good long term investmentConsistent high-yield stocks - Jammu Links News
111 Inc ADR Options Removed, Reports Q4 2024 Earnings - AInvest
20 hospitalized after possible carbon monoxide, methane leak at Port Arthur facility - 12newsnow.com
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) - The Manila Times
Ultragenyx Pharmaceutical Inc. Receives Complete Response Letter from FDA for UX111 Gene Therapy for Sanfilippo Syndrome Type A - Quiver Quantitative
Financial Review: 111 (YI) & The Competition - Defense World
Don't fall for video of King Charles III speaking 'to the world' about Trump's Iran strikes - Snopes
Companies Reporting Earnings on June 19, 2025: 111 YI, Addex Therapeutics, Cheetah Mobile - AInvest
Grandview Asset Management LLC Acquires Shares of 111 MercadoLibre, Inc. (NASDAQ:MELI) - MarketBeat
Short Interest in 111, Inc. (NASDAQ:YI) Decreases By 32.7% - Defense World
Weiss Ratings Reiterates Sell (E+) Rating for 111 (NASDAQ:YI) - Defense World
Qlaris Bio Announces Development of Fixed-Dose Combination Therapy with QLS‑111 and Latanoprost for the Treatment of Glaucoma - BioSpace
Kalkine : HealthEquity’s Role in Evolving Health Services on Nasdaq Today - Kalkine Media
Job losses at Totally as urgent NHS call firm collapses - BBC
Kalkine: Exelixis Joins Momentum Wave Ahead of Russell 1000 Rebalance - Kalkine Media
111 Capital Invests $12.89 Million in Amazon.com, Inc. (NASDAQ:AMZN) - Defense World
111 Capital Purchases Shares of 129,710 NVIDIA Co. (NASDAQ:NVDA) - Defense World
111 Inc Adr (YI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
1.21%
자본화:
|
볼륨(24시간):